Fermenta Biotech (NSE:FERMENTA) Notes Receivable: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:FERMENTA Fermenta Biotech Ltd NSE:FERMENTA
54 GF Score
Price ₹456.10
GF Value ₹315.37
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Fermenta Biotech Notes Receivable?

Fermenta Biotech NSE:FERMENTA 54 Notes Receivable is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:FERMENTA with a GF Score™ of 54/100 and a GF Value™ of ₹315.37 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Fermenta Biotech's Notes Receivable for the quarter that ended in Jun. 2026 was ₹0 Mil.

Fermenta Biotech Notes Receivable Related Terms

Fermenta Biotech Notes Receivable Historical Data

* Premium members only.

The historical data trend for Fermenta Biotech's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fermenta Biotech Notes Receivable Chart

Fermenta Biotech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fermenta Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:FERMENTA
54GF Score
Fermenta Biotech Ltd NSE:FERMENTA
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fermenta Biotech Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0 Mil mean?
Fermenta Biotech (NSE:FERMENTA) has a Notes Receivable of ₹0 Mil as of Jun. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Fermenta Biotech and its competitors.
Is Fermenta Biotech's Notes Receivable too high?
Fermenta Biotech's current Notes Receivable is ₹0 Mil. Overall, Fermenta Biotech has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fermenta Biotech's Notes Receivable compare to ?
Fermenta Biotech's Notes Receivable of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Fermenta Biotech and its competitors. Fermenta Biotech's current Notes Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fermenta Biotech stock overvalued right now?
Based on GuruFocus' analysis, Fermenta Biotech (NSE:FERMENTA) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹315.37, compared to a current price of ₹456.10 — trading 44.6% above its estimated fair value. The current Notes Receivable is ₹0 Mil. Fermenta Biotech's overall GF Score™ is 54/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Fermenta Biotech (NSE:FERMENTA), the current Notes Receivable is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fermenta Biotech (NSE:FERMENTA) Overvalued in 2026?

Based on GuruFocus' analysis, Fermenta Biotech stock appears to be overvalued. The current stock price of ₹456.10 is trading 44.6% above its estimated GF Value™ of ₹315.37. GuruFocus considers Fermenta Biotech to be Significantly Overvalued.

Key valuation signals for NSE:FERMENTA:

  • Notes Receivable: ₹0 Mil
  • GF Value™: ₹315.37 vs. price of ₹456.10 (44.6% above fair value)
  • GF Score™: 54/100 with 3 warning signs

No single metric tells the full story. See the NSE:FERMENTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fermenta Biotech Business Description

Comparable Companies
Other Exchanges 506414:India
Address Ghodbunder Road, A -1501, Thane One, DIL Complex, Majiwada, Thane (West), Thane, MH, IND, 400610
Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments namely Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.
54GF Score

Get the complete analysis for NSE:FERMENTA

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹456.10
Price
₹315.37
GF Value